4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 725.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,350.00p
  • 52 Week Low: 703.85p
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 13
  • Market Cap: £112.65m

Latest Deals

Traded Action Notifier PriceAmountValue
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Latest Notification of Holdings

Traded Action Notifier AmountValue*
13-Nov-24 Notification of Holding Joseph Manuel Fernández 0 £0.00
13-Nov-24 Notification of Holding David John Roth 0 £0.00
13-Nov-24 Notification of Holding Heikki Lanckriet 0 £0.00

* Value is calculated by using the current share price multiplied by the amount held.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 725.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,350.00p
52 Week Low 703.85p
Volume 13
Shares Issued 15.54m
Market Cap £112.65m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
08:00 13 @ 705.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page